During the past decade, Northern Montana Hospital conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 99 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 17 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Northern Montana Hospital" #1 sponsor was "National Cancer Institute (NCI)" with 47 trials, followed by "Alliance for Clinical Trials in Oncology" with 34 trials sponsored, "SWOG Cancer Research Network" with 33 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 4 trials sponsored and "NSABP Foundation Inc" with 4 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Northern Montana Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 82 trials as a collaborator, "Cancer and Leukemia Group B" with 9 trials as a collaborator, "NCIC Clinical Trials Group" with 9 trials as a collaborator, "SWOG Cancer Research Network" with 9 trials as a collaborator and "NRG Oncology" with 7 trials as a collaborator. Other collaborators include 14 different institutions and companies that were collaborators in the rest 15 trials.

According to Clinical.Site data, the most researched conditions in "Northern Montana Hospital" are "Breast Cancer" (15 trials), "Lung Cancer" (13 trials), "Lymphoma" (10 trials), "Leukemia" (8 trials) and "Neurotoxicity" (5 trials). Many other conditions were trialed in "Northern Montana Hospital" in a lesser frequency.

Most popular intervention types in "Northern Montana Hospital" are "Drug" (112 trials), "Other" (67 trials), "Biological" (54 trials), "Radiation" (12 trials) and "Procedure" (10 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (32 trials), "Bevacizumab" (20 trials), "Paclitaxel" (17 trials), "Quality-of-Life Assessment" (16 trials) and "placebo" (13 trials). Other intervention names were less common.

The vast majority of trials in "Northern Montana Hospital" are 108 trials for "All" genders, 21 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Northern Montana Hospital". undefined are not yet recruiting, undefined are recruiting, 31 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 85 completed trials in Northern Montana Hospital, undefined suspended trials, and 14 terminated clinical trials to date.

Out of the total trials that were conducted in Northern Montana Hospital, 6 "Phase 1" clinical trials were conducted, 51 "Phase 2" clinical trials and 64 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".